scholarly journals Transcatheter Tricuspid Valve-in-Valve Replacement by Transatrial Approach

2020 ◽  
Vol 10 (18) ◽  
pp. 6540
Author(s):  
Grigore Tinica ◽  
Igor Nedelciuc ◽  
Iulian Rotaru ◽  
Flavia Catalina Corciova ◽  
Dumitru Grajdianu ◽  
...  
Keyword(s):  
Heart Failure ◽  
Tricuspid Valve ◽  
Clinical Status ◽  
Severe Heart Failure ◽  
Late Presentation ◽  
Attractive Alternative ◽  
Novel Approach ◽  
Valve In Valve ◽  
Valve Implantation ◽  
Bioprosthetic Valves

Reoperation on the tricuspid valve after prior heart valve surgery is associated with an increased operative risk due to a poor clinical status with severe heart failure and late presentation. Transcatheter tricuspid valve-in-valve implantation emerged as an attractive alternative to a high-risk redo surgery. The authors report a case of successful treatment of a failed bioprosthetic tricuspid valve in a 58-year-old woman with severe heart failure, decompensated cardiac cirrhosis and atrial fibrillation using transcatheter tricuspid valve-in-valve implantation of a Sapien 3 valve (Edwards Lifesciences, Irvine, California) via a transatrial approach. This case demonstrates the efficiency of this novel approach for the treatment of dysfunctional surgical tricuspid bioprosthetic valves and the technical feasibility and safety of a rarely used route.

Valve-in-Valve in the Tricuspid Position for a Stenosed Bioprosthesis

2015 ◽  
Vol 16 (2) ◽  
pp. 96 ◽  
Author(s):  
Ziv Beckerman ◽  
Oved Cohen ◽  
Arthur Kerner ◽  
Ariel Roguin ◽  
Avishai Ziser ◽  
...  
Keyword(s):  
Cardiac Surgery ◽  
Tricuspid Valve ◽  
Open Heart ◽  
Technical Feasibility ◽  
Edwards Sapien ◽  
Valve In Valve ◽  
Transcatheter Valve ◽  
Valve Implantation ◽  
Bioprosthetic Valves ◽  
Surgery In Elderly

The strategy of transcatheter valve-in-valve implantation into failing mitral and aortic bioprosthetic valves is a documented approach. It allows one to avoid performing a high-risk repeat cardiac surgery in elderly patients with multiple comorbidities. Tricuspid valve-in-valve implantation has been documented only a few times in the literature. We report the case of a 65-year-old woman with a failing bioprosthetic tricuspid valve who had undergone 3 prior open heart operations. We attempted a transatrial transcatheter approach and successfully deployed a 29-mm Edwards Sapien balloon-expandable bioprosthesis into a severely stenotic tricuspid bioprosthesis. This case demonstrates the technical feasibility and safety of this approach.

scholarly journals Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves

Circulation ◽  
2016 ◽  
Vol 133 (16) ◽  
pp. 1582-1593 ◽  
Author(s):  
Doff B. McElhinney ◽  
Allison K. Cabalka ◽  
Jamil A. Aboulhosn ◽  
Andreas Eicken ◽  
Younes Boudjemline ◽  
...  
Keyword(s):  
Tricuspid Valve ◽  
Valve In Valve ◽  
Valve Implantation ◽  
Bioprosthetic Valves

Percutaneous Transjugular Tricuspid Valve-In-Valve Implantation for Degenerated Surgical Bioprosthetic Valve

2020 ◽  
Vol 21 (6) ◽  
pp. 808-809
Author(s):  
Francesco Melillo ◽  
Luca A. Ferri ◽  
Alessandro Beneduce ◽  
Luca Baldetti ◽  
Marco Ancona ◽  
...  
Keyword(s):  
Tricuspid Valve ◽  
Bioprosthetic Valve ◽  
Valve In Valve ◽  
Valve Implantation

scholarly journals Hemodialysis vascular access affects heart function and outcomes: Tips for choosing the right access for the individual patient

2020 ◽  
pp. 112972982096931
Author(s):  
Jan Malik ◽  
Carlo Lomonte ◽  
Joris Rotmans ◽  
Eva Chytilova ◽  
Ramon Roca-Tey ◽  
...  
Keyword(s):  
Heart Failure ◽  
Vascular Access ◽  
Heart Function ◽  
Clinical Status ◽  
Severe Heart Failure ◽  
Dialysis Patients ◽  
Av Fistula ◽  
Hemodialysis Vascular Access ◽  
Cardiovascular Morbidity And Mortality ◽  
The Individual

Chronic kidney disease is associated with increased cardiovascular morbidity and mortality. A well-functioning vascular access is associated with improved survival and among the available types of vascular access the arterio-venous (AV) fistula is the one associated with the best outcomes. However, AV access may affect heart function and, in some patients, could worsen the clinical status. This review article focuses on the specific cardiovascular hemodynamics of dialysis patients and how it is affected by the AV access; the effects of an excessive increase in AV access flow, leading to high-output heart failure; congestive heart failure in CKD patients and the contraindications to AV access; pulmonary hypertension. In severe heart failure, peritoneal dialysis (PD) might be the better choice for cardiac health, but if contraindicated suggestions for vascular access selection are provided based on the individual clinical presentation. Management of the AV access after kidney transplantation is also addressed, considering the cardiovascular benefit of AV access ligation compared to the advantage of having a functioning AVF as backup in case of allograft failure. In PD patients, who need to switch to hemodialysis, vascular access should be created timely. The influence of AV access in patients undergoing cardiac surgery for valvular or ischemic heart disease is also addressed. Cardiovascular implantable electronic devices are increasingly implanted in dialysis patients, but when doing so, the type and location of vascular access should be considered.

Sign in / Sign up

Export Citation Format

Share Document